Information  X 
Enter a valid email address

CambridgeCognitionHldgs Ord 1P (COG)

Related News

22-Sep-2020 09:45 AM

Cambridge Cognition slashes first-half losses as new contract wins boost revenue

Cambridge Cognition, developer and marketer of digital solutions to assess brain health, cut first-half losses by 75% on higher revenue thanks to new contract wins. For the six months ended 30 June 2020, pre-tax losses fell to £0.43m on-year and
05-May-2020 10:02 AM

Cambridge Cognition reports wider losses as revenue hurt by lower-than-expected sales

Neuroscience technology developer Cambridge Cognition reported wider losses as revenue fell and said coronavirus-led disruptions had delayed the closing of some customer contracts. For the year ended 31 December 2019, pre-tax losses widened to £3.
19-Feb-2020 07:55 AM

Cambridge Cognition warns on revenue; sees signs of improved performance

Cognitive assessment software provider Cambridge Cognition said it expected to report lower revenue this year, but added that efforts to overcome short-term market factors had improved performance. For the year through December 2019, the company expect
19-Sep-2019 07:12 AM

Cambridge Cognition interims show revenue drop and losses widen

Cambridge Cognition announced its interim results this morning with revenue of £2.17m (H1 2018: £2.75m) and the loss before tax widening to £1.74m (H1 2018: £1.02m loss) In H1, sales were lower in the core clinical trials business
27-Aug-2019 07:25 AM

Cambridge Cognition expects to report wider losses as revenues fall in H1

Cambridge Cognition said it expected to report wider losses following lower revenues in the first half of the year and increased costs. The loss for the year was expected to be in the region of £2.80m, compared with a loss of £1.44m a year e
19-Dec-2018 09:01 AM

Cambridge Cognition forecasts wider losses on lower revenue

Cambridge Cognition said it expected to post a larger loss than that of last year as a change in the way it recognised revenue was expected hurt results. Under IFRS15, the new financial standard on revenue recognition, revenue was expected to be in the
31-May-2018 08:30 AM

Broker Forecast - finnCap issues a broker note on Cambridge Cognition Holdings

finnCap today reaffirms its corporate investment rating on Cambridge Cognition Holdings (LON:COG) and raised its price target to 175p (from 155p). Story provided by Broker Forecasts data provided by
26-Mar-2018 07:58 AM

Cambridge Cognition secures major new pharmaceutical contract, wins grant

Cambridge Cognition Holdings said Monday it secured a major new pharmaceutical clinical trial contract and a Digital Health Catalyst grant from Innovate UK. The new clinical trial contract is the larger of the two contracts, collectively totalling &poun
22-Mar-2018 08:28 AM

Cambridge Cognition swings to loss as hardware sales tumble

Cambridge Cognition reported a loss before tax of £0.28m for the year to the end of December, compared with a profit of £0.11m in 2016 as hardware sales slumped. Total revenues fell 2% to £0.15m as hardware revenue fell 80.4% to &poun
17-Jan-2018 11:57 AM

Steven Powell, CEO of Cambridge Cognition to present at the London Growth and Innovation Forum on 30

The Growth and Innovation Forum is the UK's only growth and technology focussed investment show and is an opportunity for Institutional and Private Investors to connect with top experts who will share their in-depth knowledge of investing and meet di
10-Jan-2018 11:30 AM

Broker Forecast - finnCap issues a broker note on Cambridge Cognition Holdings

finnCap today reaffirms its corporate investment rating on Cambridge Cognition Holdings (LON:COG) and cut its price target to 155p (from 180p). Story provided by
10-Jan-2018 09:25 AM

Cambridge Cognition revenues to be below forecast

Cambridge Cognition Holdings expects revenue for the year ended 31 Dec to be marginally below the £6.9m reported in 2016 but with the sales order pipeline value up 56% on the prior year. The company said it had expected to sign two large contracts
28-Nov-2017 09:12 AM

Cambridge Cognition reveals positive study results at summit

Cambridge Cognition Holdings has released positive results from a pilot study to evaluate cognition and mood using wearable technology in patients with major depressive disorder (MDD) at the 2017 International CNS summit in Boca Raton, Florida. The study
21-Sep-2017 10:00 AM

Broker Forecast - finnCap issues a broker note on Cambridge Cognition Holdings

finnCap today reaffirms its corporate investment rating on Cambridge Cognition Holdings (LON:COG) and raised its price target to 180p (from 130p). Story provided by
21-Sep-2017 09:17 AM

Cambridge Cognition losses widen

Cambridge Cognition's pre-tax losses rose to £0.39m in the six months to the end of June - up from £0.15m last time. Revenues of £3.21m were down from £3.26m a year ago and adjusted pre-tax losses increased to £0.29m f
12-Sep-2017 07:30 AM

Cambridge Cognition gets £0.3m of R&D funding

Cambridge Cognition Holdings has been awarded £0.3m of R&D funding by the UK's innovation agency, Innovate UK, to develop a novel digital health system which will elicit and automatically analyse pain-related signals in human speech. Cambridge
07-Jun-2017 08:15 AM

Cambridge Cognition speech recognition for clinical trials

Cambridge Cognition Holdings has announced its application of automatic speech recognition technology to develop new products to enable scaleable, language-based clinical assessment to reduce clinical trial variability and costs and increase overall clini
29-Mar-2017 09:50 AM

Broker Forecast - finnCap issues a broker note on Cambridge Cognition Holdings

finnCap today reaffirms its corporate investment rating on Cambridge Cognition Holdings (LON:COG) and raised its price target to 130p (from 115p). Story provided by
16-Mar-2017 09:28 AM

Cambridge Cognition's CANTAB used in Amgen study

Cambridge Cognition has reported on its involvement in Amgen's EBBINGHAUS study, full results of which will be presented at the American College of Cardiology Annual Scientific Session on 18 March. The EBBINGHAUS researchers used Cambridge Cognition
24-Feb-2017 08:18 AM

Takeda and Cognition Kit pilot app for depression

Takeda Pharmaceuticals USA and Cognition Kit - a joint venture between Cambridge Cognition and Ctrl Group - have announced a collaboration to pilot the use of a specially designed app on an Apple Watch wearable to monitor and assess cognitive function i
25-Jan-2017 08:41 AM

Cambridge Cognition gets US clearance for CANTAB Mobile

Cambridge Cognition Holdings has received clearance from the US Food and Drug Administration to market CANTAB Mobile as a medical device in the US. CANTAB Mobile is designed to detect clinically-relevant memory impairment in older adults at the point of
13-Oct-2016 02:15 PM

Cambridge Cognition unveils series of contracts

Cambridge Cognition announces a series of new contracts worth more than £0.25m to assess, through CANTAB Connect, the abuse potential of investigational drugs in a new market application for the Company. Since launching its cloud-based CANTAB Conne
29-Sep-2016 07:37 AM

Cambridge Cognition wins major contracts

Cambridge Cognition Holdings has signed two major contracts using the company's CANTAB Connect technology. The contracts totalling US$3.67million are with US biopharmaceutical companies for late stage clinical trials and will contribute US$1.07 mi
16-Aug-2016 08:09 AM

Cognition Kit study on real-time brain measurement

Cambridge Cognition says results from a new technology feasibility study demonstrate for the first time that consumer grade wearables such as the Apple Watch and Microsoft Band can be used to accurately measure clinically relevant cognitive performance i
20-Jul-2016 07:58 AM

Cambridge Cognition wins new contract

Cambridge Cognition (COG) secured its largest contract to date for the CANTAB Connect Research product, which is marketed for use in research projects by academic and small biotechnology research groups. Worth an estimated £0.5 million, the contrac
Top categories
Company finder

a d v e r t i s e m e n t